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Various forms of stress induce pathways that converge on the phosphorylation of the alpha () subunit of eukaryotic
translation initiation factor eIF2 at serine 51 (S51), a modiﬁcation that results in a global inhibition of protein synthesis. In many
cases eIF2 phosphorylation is a biological response that facilitates cells to cope with stressful environments. Glucose
deﬁciency, an important form of stress, is associated with an induction of apoptosis. Herein, we demonstrate that eIF2
phosphorylation is a key step in maintaining a balance between the life and death of a glucose-deﬁcient cell. That is, eIF2
phosphorylation acts as a molecular switch that shifts cells from a proapoptotic to a cytoprotective state in response to
prolonged glucose deﬁciency. This adaptation process is associated with the timely expression of proteins and activation of
pathways with signiﬁcant contributions to cell survival and adaptation including the X-linked inhibitor of apoptosis protein
(XIAP). We also show that among the eIF2 kinases GCN2 plays a proapoptotic role whereas PERK and PKR play a
cytoprotective one in response to glucose deﬁciency. Our data demonstrate that eIF2 phosphorylation is a signiﬁcant
determinant of survival and adaptation of glucose-deﬁcient cells with possible important implications in biological processes
that interfere with glucose metabolism.
INTRODUCTION
Glucose molecules are a fundamental source of fuel for phys-
iological processes. Energy in the form of adenosine triphos-
phate (ATP) is extracted from glucose through glycolysis to
produce two ATP molecules. Subsequently, in the presence of
sufﬁcient oxygen, the energy acquiring process continues to
produce thirty-six ATP molecules through oxidative phos-
phorylation (Pelicano et al., 2006). When eukaryotic cells en-
counter conditions of limited oxygen supply, they are no
longer capable of utilizing oxygen as the ﬁnal electron acceptor
during oxidative phosphorylation, and therefore cells resort to
extracting energy through glycolysis (Pelicano et al., 2006). Otto
Warburg discovered that cancer cells produce most of their
ATP through glycolysis even in the presence of sufﬁcient oxy-
gen, a phenomenon commonly known as “aerobic glycolysis”
or the “Warburg effect” (Warburg et al., 1927). This shift of
glucose metabolism from oxidative phosphorylation to glyco-
lysis, although inefﬁcient in energy production, provides can-
cer cells with several growth advantages over the surrounding
normal cells, such as the ability to survive conditions of ﬂuc-
tuating oxygen levels (Pouyssegur et al., 2006), to favor tumor
invasion (Swietach et al., 2007), and to suppress anticancer
immune factors (Fischer et al., 2007). Most importantly, prolif-
erating cancer cells can utilize intermediates of the glycolytic
pathway as precursors for synthesis of amino acids, nucleic
acids, and lipids (Kroemer and Pouyssegur, 2008). Given the
above-mentioned importance of glucose, decreased glucose
uptake has been linked to the induction of apoptosis in most
cells (Moley and Mueckler, 2000). The molecular mechanisms
that underlie the proapoptotic effects of glucose deﬁciency are
complex and in some cases cell type speciﬁc and involve an
interplay between tumor suppressor and oncogenic pathways
including p53, the hypoxia inducible factor 1 (HIF-1) and
AKT/protein kinase B (PKB; Kroemer and Pouyssegur, 2008).
Glucose deﬁciency is a strong inducer of the unfolded
protein response (UPR), which was ﬁrst characterized as a
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3220transcriptional up-regulation of a set of genes that encode
glucose-regulated proteins (GRPs) in response to glucose/en-
ergy deprivation (Kozutsumi et al., 1988). As glucose levels
decline, ATP supply decreases, so protein folding becomes less
efﬁcient in the lumen of endoplasmic reticulum (ER), leading to
the accumulation of unfolded or misfolded proteins. UPR is
now considered as an important signaling pathway evolved in
the ER to cope with stress induced by protein misfolding. An
important stress sensor of UPR is the PKR-like ER-associated
kinase (PERK), which mediates the phosphorylation of the 
subunit of the eukaryotic translation initiation factor eIF2 at
serine 51 (S51; Harding et al., 1999). Phosphorylated eIF2
prevents the recycling of the eIF2-bound GDP to GTP by the
guanine nucleotide exchange factor (GEF) eIF2B (Sonenberg
and Hinnebusch, 2009). As such, formation of the eIF2-GTP-
tRNAMet ternary complex is impeded resulting in the inhibi-
tion of translation initiation (Sonenberg and Hinnebusch,
2009). Although eIF2 phosphorylation leads to a global inhi-
bition of protein synthesis, speciﬁc mRNAs can bypass this
limitation and be efﬁciently translated under conditions of
increased eIF2 phosphorylation. Translation of these mRNAs
is facilitated by the presence of an internal ribosomal entry site
(IRES) in their 5 untranslated region (5UTR; Komar and Hat-
zoglou, 2005), or the presence of small open reading frames
(uORFs) in their 5UTRs as has been demonstrated for mRNAs
encoding for the activating transcription factor 4 (ATF4) and
ATF5 (Vattem and Wek, 2004; Zhou et al., 2008). Phosphoryla-
tion of eIF2 is mediated by a family of kinases each of which
responds to distinct forms of environmental stress (Wek et al.,
2006). In addition to PERK, the eIF2 kinase family includes
the heme-regulated inhibitor (HRI), which is activated by
iron or heme deﬁciency as well as oxidative stress, the
general control nonderepressible-2 (GCN2), which is acti-
vated by uncharged tRNA caused by amino acid deﬁciency,
and the RNA-dependent protein kinase (PKR), which is an
interferon (IFN)-inducible protein that becomes activated by
binding to double-stranded (ds) RNA.
Although eIF2 phosphorylation was previously shown to
be induced in glucose-deﬁcient cells (Scheuner et al., 2001;
Gomez et al., 2008), the biological effects of eIF2 phosphory-
lation in response to this type of stress have not been under-
stood. Also, it is not presently clear either whether PERK is the
only kinase that responds to glucose deﬁciency and mediates
the biological function of eIF2 phosphorylation (Gomez et al.,
2008). Herein, we demonstrate that eIF2 phosphorylation is
initially a proapoptotic response, which becomes cytoprotec-
tive under long-term glucose deﬁciency. Among the eIF2
kinases, PERK and PKR play a cytoprotective role as opposed
to GCN2, which is mainly proapoptotic. At the molecular level,
we show that adaptation to glucose deﬁciency is associated
with an interplay between proapoptotic and cell survival path-
ways, all of which depend on eIF2 phosphorylation and con-
verge on the regulation of caspase-3.
MATERIALS AND METHODS
Cell Culture Conditions and Treatments
HT1080 cells (CCL-121) were cultured in Dulbecco’s modiﬁed Eagle medium
(DMEM; Wisent, St.-Bruno, QC, Canada) plus 10% heat-inactivated calf se-
rum (Invitrogen, Carlsbad, CA) and 100 of U/ml penicillin-streptomycin
(Wisent). A549 cells (CCL-185), Hela cells (CCL-2), and HCT116 XIAP/
cells (Cummins et al., 2004), and isogenic wild-type and XIAP/ mouse
embryonic ﬁbroblasts (MEFs; Rumble et al., 2008), were maintained in DMEM
plus 10% fetal bovine serum (Wisent) and 100 U/ml penicillin-streptomycin
(Wisent). MEFs lacking PERK (Harding et al., 2000b), PKR (Durbin et al., 2002),
GCN2 (Maurin et al., 2005) or that were deﬁcient in the phosphorylation of
eIF2 at S51 (i.e., eIF2A/A MEFs; Scheuner et al., 2001) together with their
isogenic wild-type counterparts were cultured as previously described (Krish-
namoorthy et al., 2008). The DMEM used contains 50 mM glucose unless stated
otherwise. For glucose deprivation, cells were maintained in glucose-deplete
DMEM (Invitrogen) supplemented with serum and antibiotics as described
above. 2-Deoxyglucose (2-DG; BioShop, Burlington, ON, Canada) was
dissolved in sterile double-distilled water and used at a concentration of 50
mM in cells grown under glucose-replete DMEM conditions. Thapsigargin
(TG; Sigma, St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO)
and used at a concentration of 1 M.
Protein Extraction and Immunoblot Analysis
Lysis of the cells, preparation of protein extracts, and quantiﬁcation of pro-
teins were performed as previously described (Baltzis et al., 2007). Preparation
of protein extracts for detection of caspase-12 and caspase-3 was performed as
reported (Cheong et al., 2003). Immunoblotting analysis was performed as
previously described (Baltzis et al., 2007). The primary antibodies included
anti-CHOP/GADD135 polyclonal antibody (sc-575, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA), anti-GRP78/BiP polyclonal antibody (sc-13968, Santa
Cruz), anti-eIF2 mAb (L575A5, Cell Signaling, Beverly, MA), anti-eIF2
Ser(P)-51 polyclonal antibody (44728G, Invitrogen), anti-actin C4 mAb (MP
Biomedicals, Solon, OH), anti--tubulin mAb (32–2600, Invitrogen), anti-
ATF4 polyclonal antibody (10835, Proteintech, Chicago, IL), anti-XIAP and
anti-cIAP1/2 polyclonal antibodies (Ungureanu et al., 2006), anti-AKTSer(P)-
473 polyclonal antibody (9271, Cell Signaling), anti-AKT polyclonal antibody
(9272, Cell Signaling), anti-TRAF2 polyclonal antibody (sc-7346, Santa Cruz),
anti-Bcl-xL polyclonal antibody (2764, Cell Signaling), anti-S6 Ser(P)235/236
polyclonal antibody (2211, Cell Signaling), anti-S6 polyclonal antibody (Cell
Signaling, 2212), anti-caspase-12 polyclonal antibody (2202, Cell Signaling),
and anti-caspase-3 polyclonal antibody (9661, Cell Signaling). All antibodies
were used at a ﬁnal concentration of 0.1–1 g/ml. After incubation with
anti-mouse IgG or anti-rabbit IgG antibodies conjugated to horseradish per-
oxidase (HRP), proteins were visualized with enhanced chemiluminescence
(ECL) reagent (Perkin Elmer Life Sciences, Waltham, CA) detection system
according to the manufacturer’s instructions. Quantiﬁcation of protein bands was
performed by densitometry using Scion Image (Frederick, MD) from NIH.
Polysome Proﬁles and mRNA Quantiﬁcation
Polysome proﬁles were performed as previously described (Baltzis et al.,
2007). RNA from each fraction of polysome analysis was isolated using Trizol
reagent (Invitrogen). The relative distributions of speciﬁc mRNAs were mon-
itored by reverse transcriptase (RT)-quantitative PCR (qPCR) as previously
described (Li et al., 2008). Brieﬂy cDNA was synthesized with the SuperScript
III kit (Invitrogen), and the abundance of each cDNA was quantiﬁed by
real-time PCR (qRT-PCR) using the Power SYBR Green PCR Master Mix
(Applied Biosystem, Foster City, CA; Li et al., 2008). The primers that were
used to visualize XIAP mRNA are as follows: XIAP forward primer 5-
CGAGCTGGGTTTCTTTATACCG-3, XIAP reverse primer 5-GCAATTT-
GGGGATATTCTCCTGT-3, whereas those used to visualize Bcl-xL are as
follows: Bcl-xL forward primer 5-GACAAGGAGATGCAGGTATTGG-3,
Bcl-xL reverse primer 5-TCCCGTAGAGATCCACAAAAGT-3.
[35S]Methionine Labeling
[35S]Methionine labeling of cells was performed as previously described
(Raven et al., 2008) with minor modiﬁcations. Brieﬂy, cells were treated with
2-DG , or incubated in glucose-deplete media, or treated with 1 MT Gi n
glucose-replete media for various periods of time as speciﬁed in each experiment.
EXPRESS 35S protein-labeling mix (PerkinElmer, Norwalk, CA; NEG-072007MC)
was added to the cells at a ﬁnal concentration of 30 Ci/ml for 30 min before
protein extraction. The radioactivity was measured in 100 g of protein extracts
as described (Raven et al., 2008).
Flow Cytometry Analysis
Cells were prepared for ﬂow cytometry as previously described (Kazemi et al.,
2004). Data were analyzed using the WinMDI 2.8 software (Scripps Research
Institute, San Diego, CA). Samples were gated on a dot-plot showing the
forward scatter and side scatter to exclude debris not within normal cell size.
RNA Interference
Hela cells were transfected with nonspeciﬁc scrambled small interfering RNA
(siRNA; Dharmacon, Boulder, CO) or human XIAP siRNA (Dharmacon;
L-004098) by Lipofectamine 2000 (Invitrogen) according to manufacturer’s pro-
tocol. Brieﬂy, cells were plated in six-well plates, such that cells would be 50%
conﬂuent the following day. The next day cells are incubated with transfection
reagent and 50 M of siRNA in serum-free media for 4 h. Cells were then
incubated in media containing 10% serum but lacking antibiotics for 24 h before
being treated with glucose deprivation or 2-DG for an additional 24 h.
RESULTS
Human Tumor Cells Respond to Glucose Deﬁciency by
Inducing eIF2 Phosphorylation
A previous study showed that eIF2 phosphorylation is
induced in human pancreatic -cells under conditions of
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whether this is applicable to other cell types, we used hu-
man ﬁbrosarcoma HT1080 cells and the human lung cancer
A549 cells to assess the phosphorylation of eIF2 at S51
under conditions of glucose deﬁciency. We observed that
eIF2 phosphorylation was increased in HT1080 cells under
conditions of short as well as prolonged glucose deprivation
(Figure 1Aa). Induction of eIF2 phosphorylation was asso-
ciated with an increased expression of the glucose-regulated
protein 78/immunoglobulin binding protein (GRP78/BiP;
Figure 1Ac), which is an indicator of the induction of the
UPR. Phosphorylation of eIF2 and GRP78/BiP expression
were also increased in A549 cells after treatment with 2-DG,
a modiﬁed glucose molecule that acts as an inhibitor of
glycolysis (Kang and Hwang, 2006; Figure 1B). These data
indicated that tumor cells respond to glucose deﬁciency by
increasing eIF2 phosphorylation and GRP78/BiP levels
probably due to induction of UPR.
Induction of eIF2 Phosphorylation Inﬂuences Cell Fate
during Glucose Deﬁciency
To address the signiﬁcance of eIF2 phosphorylation, we
assessed the effects of glucose deﬁciency on MEFs contain-
ing either a wild-type allele of eIF2 (eIF2S/S) or a knockin
eIF2 allele bearing the S51A mutation (eIF2A/A). First,
we veriﬁed that eIF2 phosphorylation and GRP78/BiP ex-
pression were both induced in wild-type MEFs under con-
ditions of glucose deprivation or 2-DG treatment (Figure
2A). Then, we examined the susceptibility of eIF2S/S and
eIF2A/A MEFs to glucose deﬁciency by measuring the
population of cells in sub-G1 after treatment (Supplemen-
tary Figure 1). We found that glucose deprivation or 2-DG
resulted in a higher amount of death in eIF2S/S MEFs than
in eIF2A/A MEFs after 24 h of treatment (Figure 2B and
Supplementary Figure 1). However, when cells were main-
tained without glucose or were treated with 2-DG for 48 h,
we noticed that eIF2A/A MEFs became more proapoptotic
than eIF2S/S MEFs (Figure 2B and Supplementary Figure
1). Between the two treatments of glucose deﬁciency, we
noted that 2-DG was more efﬁcient than glucose deprivation
in inducing the death of eIF2S/S and eIF2A/A MEFs,
possibly due to the strong inhibitory effects of 2-DG on
glucose metabolism (Figure 2B). These data provided evi-
dence for two different functions of eIF2 phosphorylation
in glucose-deﬁcient cells. That is, increased eIF2 phosphor-
ylation in response to short-term glucose deﬁciency elicits a
proapoptotic response that is counteracted by the induction
of a cytoprotective response under prolonged stress.
Distinct Roles of the eIF2 Kinases in Cells Maintained
under Glucose Deﬁciency
To identify the biological roles of the eIF2 kinases in glu-
cose-deﬁcient cells, we used MEFs that were devoid of each
eIF2 kinase as well as wild-type isogenic MEFs (Figure 3).
Because the function of HRI is restricted to erythroid cells,
we focused our efforts on PKR, PERK, or GCN2. We found
that both PKR and PERK played a cytoprotective effect given
that PERK/ and PKR/ MEFs were more susceptible to
the proapoptotic effects of glucose deprivation or 2-DG treat-
ment than their corresponding wild-type isogenic MEFs
(Figure 3, A and B, Supplementary Figures 2 and 3). On the
other hand, GCN2 conveyed a proapoptotic effect because a
higher number of GCN2/ than GCN2/ MEFs was sus-
ceptible to death by glucose deprivation or 2-DG treatment
(Figure 3C and Supplementary Figure 4). It is of interest that
treatment with 2-DG for 48 h yielded a signiﬁcant amount of
death in both GCN2/ and GCN2/ MEFs, making it
difﬁcult to conclude on the proapoptotic function of GCN2
for this particular time point (Figure 3C). From these exper-
iments, we noticed that glucose deﬁciency did not produce
an identical response in all wild-type MEFs. That is, al-
though PERK/ (Figure 3A) and PKR/ MEFs (Figure
3B) were similarly susceptible to death by glucose deﬁ-
ciency, GCN2/ MEFs exhibited an increased sensitivity to
glucose deﬁciency compared with PERK/ and PKR/
MEFs (Figure 3C). These different responses of the wild-type
MEFs were most likely due to the differences in the genetic
background of the cells. Nevertheless, the role of each eIF2
kinase in cell death induced by glucose deﬁciency is well
supported by the fact that the data were obtained from the
analysis of isogenic pairs of MEFs. The implication of all
three eIF2 kinases in regulation of cell death by glucose
deﬁciency implied a certain degree of redundancy for in-
ducing eIF2 phosphorylation. This is consistent with our
observations that induction of eIF2 phosphorylation was
still detectable in MEFs deﬁcient in each eIF2 kinase in
response to glucose deprivation or 2-DG treatment (Supple-
mentary Figure 5).
Figure 1. Glucose deﬁciency induces eIF2 phosphorylation in
human tumors. HT1080 cells (A) and A549 cells (B) were maintained
in media containing glucose (Con; A, B), media lacking glucose
(Gluc; A) or in media containing glucose supplemented with 50
mM 2-deoxyglucose (2-DG; B) for the indicated times. (A and B)
Whole cell extract (50 g of protein) was used for immunoblot
analysis with anti-eIF2-pSer51 antibody (a), anti-eIF2 antibody
(b), anti-BiP/GRP78 antibody (c), anti-tubulin antibody (Ad) or
anti-actin antibody (Bd). The ratio of phosphorylated to total protein
of eIF2 is indicated (a/b). Quantiﬁcation of protein bands was
performed by densitometry using Scion Image from NIH. The data
represent one of three reproducible experiments. The ratio was set
to 1 for each time point control (untreated).
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Independent of eIF2 Phosphorylation
To address the mechanisms of regulation of apoptosis, we
assessed the role of eIF2 phosphorylation in regulation of
protein synthesis in cells maintained under glucose deﬁ-
ciency. To do so, eIF2S/S and eIF2A/A MEFs were sub-
jected to metabolic labeling with [35S]methionine under con-
ditions of glucose starvation or 2-DG treatment. As control,
cells were subjected to ER stress after treatment with TG. We
observed that the rates of protein synthesis were signiﬁ-
cantly reduced at comparable levels in both eIF2S/S and
eIF2A/A MEFs during glucose deprivation (Figure 4A) or
2-DG treatment (Figure 4B). On the other hand, induction of
ER stress by TG yielded a substantial inhibition of protein
synthesis in eIF2S/S MEFs but not in eIF2A/A MEFs
(Figure 4C) as previously documented (Harding et al.,
2000b). These data indicated that inhibition of protein syn-
thesis by glucose deﬁciency takes place independent of
eIF2 phosphorylation. This is different from the regulation
of protein synthesis in cells subjected to ER stress, suggest-
ing that induction of eIF2 phosphorylation by glucose de-
ﬁciency may not represent a typical ER stress response.
Induction of eIF2 Phosphorylation in Glucose-deﬁcient
Cells Affects Proteins with Distinct Roles in Cell Survival
and Cell Death
To identify the signaling pathways that determine the bio-
logical effects of eIF2 phosphorylation, ﬁrst we looked at
the regulation of caspase-3. We detected a higher amount of
activated (i.e., cleaved) caspase-3 in eIF2S/S than in
eIF2A/A MEFs at 12 h of glucose deprivation or 2-DG
treatment (Figure 5Aa, cf. lanes 2 and 3 with 5 and 6).
However, as cells were maintained under conditions of glu-
cose deﬁciency for longer periods of time, we observed a
progressive increase of cleaved caspase-3 in eIF2A/A
MEFs over eIF2S/S MEFs, which became more evident at
36 h of treatment (Figure 5Aa, cf. lanes 14 and 15 with 17 and
18). We also looked at caspase-12, which is an ER-resident
Figure 2. eIF2 phosphorylation determines cell fate during glucose deﬁciency. (A) eIF2S/S MEFs were maintained in media containing
glucose (Con), media deprived of glucose (Gluc), or media containing glucose supplemented with 50 mM of 2-deoxyglucose (2-DG) for the
indicated time points. MEFs were also treated with 1 M thapsigargin (TG) for 3 h (lane 4). Whole cell extract (50 g of protein) were
subjected to immunoblot analysis for eIF2-pSer51 (a), eIF2 (b), BiP/GRP78 (c), or actin (d). Extracts from eIF2A/A cells were included
as control (lane 16). The ratio of phosphorylated to total eIF2 protein for each lane is indicated (a/b). The ratio was set to 1 for each time
point control (untreated). Quantiﬁcation of protein bands was performed by densitometry using Scion Image from NIH. The data represent
one of two reproducible experiments. (B) eIF2S/S and eIF2A/A MEFs were treated as in A for 24 or 48 h. The percentage of cells in sub-G1
phase, which represents cell death, was measured by propidium iodide staining and ﬂow cytometry analysis (see also Supplementary Figure
1). Histograms show the average cell death  SEM calculated from seven reproducible experiments. Two-tailed t test: *p  0.05, **p  0.01.
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caspase-9 and -3 (Masud et al., 2007). We detected a higher
amount of cleaved caspase-12 in eIF2A/A than in eIF2S/S
cells, which was further increased with the time of glucose
deprivation or 2-DG treatment (Figure 5Ab). The levels of
cleaved caspase-12 were proportional to the levels of cleaved
caspase-3 in eIF2A/A cells at 24 or 36 h of treatment,
consistent with the notion that both enzymes contribute to
the increased cell death in the eIF2A/A cells at later time
points.
It is well established that induction of eIF2 phosphory-
lation leads to the activation of the ATF4-CHOP proapop-
totic pathway in response to ER stress (Harding et al., 2000a).
We observed that glucose deﬁciency resulted in a substantial
increase of ATF4 in eIF2S/S MEFs but not in eIF2A/A
MEFs for the various periods of treatment (Figure 5Ba).
Glucose deﬁciency also resulted in a substantial induction of
CHOP in eIF2S/S MEFs compared with eIF2A/A MEFs
(Figure 5Bc) most likely due to increased ATF4 (Figure 5Ba),
which acts as a transcriptional inducer of the CHOP gene
(Harding et al., 2000a). Taken together, these data suggested
that induction of eIF2 phosphorylation in glucose-deﬁcient
cells results in the activation of the ATF4-CHOP pathway,
which can account, at least in part, for the higher induction
of death in eIF2S/S than eIF2A/A cells during the early
times of glucose deﬁciency. Induction of ATF4 was associ-
ated with an up-regulation of GRP78/BiP in eIF2S/S
MEFs, which was more evident for 2-DG treatment than
glucose deprivation (Figure 5Bb). This result indicated that
glucose deprivation and 2-DG may not act through identical
Figure 3. Distinct roles of eIF2 kinases in
response to glucose deprivation. PERK/
and PERK/ MEFs (A), PKR/ and PKR/
MEFs (B) or GCN2/ and GCN2/ MEFs
(C) were kept in media containing glucose
(Con), media lacking glucose (Gluc), or me-
dia containing glucose supplemented with 50
mM of 2-deoxyglucose (2-DG) for 24 or 48 h.
The percentage of cells in sub-G1 phase, which
represents cell death, was measured by pro-
pidium iodide staining and ﬂow cytometry
analysis (see also Supplementary Figures 2–4).
Histograms show the average cell death 
SEM calculated from six, ﬁve, and seven repro-
ducible experiments for PERK, PKR and
GCN2 MEFs, respectively. Two-tailed t test:
*p  0.05, **p  0.01, ***p  0.001).
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ies (Kang and Hwang, 2006). This is further supported by
our ﬁndings showing that caspase-12 cleavage did not occur
similarly in cells subjected to 2-DG treatment or glucose
withdrawal (Figure 5Ab). Moreover, cells treated with 2-DG
were more susceptible to death than cells maintained under
glucose deprivation.
To determine the cause of accelerated death of eIF2A/A
MEFs in response to prolonged glucose deﬁciency, we ex-
amined the expression of proteins with key roles in regula-
tion of apoptosis. We found that proteins like the cellular
inhibitor of apoptosis protein 1/2 (cIAP1/2), Bcl-xL or
TRAF2 were not substantially affected by the status of eIF2
phosphorylation in cells kept under glucose deﬁciency for a
short or long period of time (Figure 5B, j–l). On the other
hand, we saw that expression of X-linked inhibitor of apo-
ptosis protein (XIAP) was substantially reduced in
eIF2A/A MEFs compared with eIF2S/S MEFs after long-
term glucose deﬁciency (Figure 5Bd). Inasmuch as XIAP
functions as an inhibitor of caspase-9 and -3 (Suzuki et al.,
2001; Morizane et al., 2005), its down-regulation can account
for the increased amount of death in eIF2A/A MEFs com-
pared with eIF2S/S MEFs after long-term glucose deﬁ-
ciency. The antiapoptotic role of XIAP in glucose-deﬁcient
cells was veriﬁed in HeLa cells in which XIAP was targeted
by siRNA, in HCT116 cells containing an homozygous de-
letion of XIAP as well as in primary XIAP/ MEFs (Figure
6 and Supplementary Figures 6-8).
Previous work demonstrated that XIAP and Bcl-xL
mRNAs contains an IRES that plays an essential role in the
translation of each mRNA species under stress (Holcik et al.,
1999; Yoon et al., 2006). Although glucose deﬁciency inhibits
protein synthesis independent of eIF2 phosphorylation
(Figure 4, A and B), we speculated that eIF2 phosphoryla-
tion might play a role in translational regulation of speciﬁc
messages under conditions of glucose deﬁciency, and XIAP
mRNA might be one of them. To test this hypothesis, we
analyzed the efﬁciency of XIAP mRNA translation in glu-
cose-deﬁcient cells by polysome proﬁles. This is a technique
that separates monosomes from polyribosomes (i.e., poly-
somes) according to their densities on a sucrose gradient.
Efﬁciently translated mRNAs are bound to polyribosomes,
whereas mRNAs that are poorly translated are found with
monosomes or disomes. We observed that glucose starva-
tion for 30 h resulted in a substantial reduction of the poly-
ribosome fractions in both eIF2S/S and eIF2A/A MEFs
(Figure 7). This observation was in line with the inhibition of
global protein synthesis in both cell types that was measured
by metabolic labeling with [35S]methionine (Figure 4A). De-
spite the translational blockade, we observed that a signiﬁ-
cant amount of XIAP as well as Bcl-xL mRNAs remained
bound to polyribosomes in glucose-deprived cells, which
was similar between eIF2S/S and eIF2A/A MEFs (Figure
7, A and B). Glucose deprivation enhanced ATF4 mRNA
translation and reduced ribosomal protein (rp) L27 mRNA
translation in eIF2S/S compared with eIF2A/A MEFs
indicating the functional role of eIF2 phosphorylation in
translational control under the experimental conditions
(Supplementary Figure 9).
The above data indicated that the mRNA of both, XIAP
and Bcl-xL can bypass the inhibitory effect of glucose depri-
vation on mRNA translation and be efﬁciently translated
under this form of stress. Given that expression of XIAP
mRNA did not differ between eIF2S/S and eIF2A/A
MEFs in the absence or presence of glucose deﬁciency (data
not shown), we conclude that down-regulation of XIAP in
eIF2A/A MEFs occurred at a posttranslational level. Be-
cause eIF2 phosphorylation can act as an inducer of PI3K-
Akt/PKB pathway under certain forms of stress (Kazemi et
al., 2007), and Akt/PKB was shown to stabilize XIAP by
phosphorylation (Dan et al., 2004), we sought to examine a
possible link between Akt/PKB and XIAP posttranslational
regulation in glucose-deﬁcient cells. We found that glucose
deprivation or 2-DG treatment did not result in a substantial
change of Akt/PKB phosphorylation at S473 or ribosomal S6
protein at S235 in both eIF2S/S and eIF2A/A MEFs when
normalized to AKT or S6 total levels, respectively (Figure
5B, f and h). These data indicated that down-regulation of
Figure 4. Glucose deﬁciency impairs protein synthesis indepen-
dent of eIF2 phosphorylation. eIF2S/S and eIF2A/A MEFs were
maintained in media containing glucose, media deprived of glucose
(Gluc; A), or media containing glucose supplemented with 50 mM
of 2-deoxyglucose (2-DG; B) for the indicated time points. The same
cells were left untreated or treated with 1 M of thapsigargin in
media containing glucose for 3 h (C). (A–C) Cells were incubated
in the presence of [35S]methionine for the last 30 min of each time
point, and the amount of [35S] labeled protein was quantiﬁed as
described in Materials and Methods. Histograms represent the
mean  SEM of two independent experiments performed in
duplicates. Two-tailed t test: *p  0.05, **p  0.01, ***p  0.001,
****p  0.0001.
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cells. These ﬁndings also suggested that the adaptation pro-
cess to glucose deﬁciency mediated by eIF2 phosphoryla-
tion does not rely on the PI3K-Akt/PKB pathway.
DISCUSSION
Glucose deﬁciency plays a key role in apoptosis through
various mechanisms including the induction of the mito-
chondrial death cascade, the expression of proapoptotic Bax,
activation of the JNK/MAPK pathway, and induction of
p53-dependent apoptosis (Moley and Mueckler, 2000). De-
spite the induction of the proapoptotic pathways, cells are
capable of adapting to prolonged glucose deﬁciency
through mechanisms that are not well understood. Here,
we provide strong evidence that eIF2 phosphorylation is
a molecular switch that controls the balance between the
death and survival of cells in response to glucose deﬁ-
ciency (Figure 8). From our work and work of others
(Scheuner et al., 2001; Gomez et al., 2008), it appears that
induction of eIF2 phosphorylation is not a cell type–
speciﬁc effect but rather a general response of cells to
glucose deﬁciency.
In line with our ﬁndings, previous work demonstrated
that eIF2 phosphorylation is an important decision maker
between cell survival and death in response to various forms
Figure 5. Induction of eIF2 phosphorylation in glucose-deﬁcient cells affects proteins with distinct functions in cell survival and cell death.
(A and B) eIF2S/S and eIF2A/A MEFs were maintained in media containing glucose (Con), glucose-free media (Gluc), or media
containing glucose supplemented with 50 mM of 2-deoxyglucose (2-DG) for the indicated times. Whole cell extract (50 g of proteins) were
subjected to immunoblot analysis for detection of cleaved caspase-3 (Aa), caspase-12 (Ab), or actin (Ac). The same amount of protein extracts
was also used to detect ATF4 (Ba), BiP/GRP78 (Bb), CHOP (Bc), XIAP (Bd), actin (Be), AKTpSer473 (Bf), AKT (Bg), S6pSer235 (Bh), S6 (Bi),
Bcl-xL (Bj), TRAF2 (Bk), and cIAP1/2 (Bl). The data represent one of three reproducible experiments. The ratio of phosphorylated to total AKT
protein for each lane is indicated (f/g). The ratio of phosphorylated to total S6 protein for each lane is indicated (h/i). The ratio was set to
1 for each time point control (untreated).
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ties of eIF2 phosphorylation are mediated by the activation
of the phosphoinositide 3-kinase (PI3K; Kazemi et al., 2007),
the induction of transcription factor NF-B (Wek et al., 2006)
or the proteasomal degradation of p53 (Baltzis et al., 2007).
The proapoptotic effects of phosphorylated eIF2 are due to
the induction of the ATF4-CHOP pathway (Wek et al., 2006)
as well as the translational down-regulation of survival pro-
teins such as Bcl-xL (Mounir et al., 2009). Consistent with a
proapoptotic role, other studies showed that eIF2 dephos-
phorylation during various forms of stress correlates with
better survival (Boyce et al., 2005). The ability of phosphor-
ylated eIF2 to control cell survival or death depends on the
type of stimuli and the speciﬁcity of the kinase that mediates
the phosphorylation of eIF2. That is, although PKR is
mainly proapoptotic (Scheuner et al., 2006; Mounir et al.,
2009), PERK is largely cytoprotective in response to various
types of stress (Harding et al., 2000b). However, unlike other
forms of stress, our data clearly show that PERK and PKR
play a cytoprotective role as opposed to GCN2, which acts in
a proapoptotic manner in response to glucose deﬁciency.
This proapoptotic role of GCN2 was unexpected given that
this eIF2 kinase is required for adaptation to amino acid
deprivation in mice (Zhang et al., 2002). As such, glucose
deﬁciency and amino acid starvation may utilize distinct
pathways that converge on eIF2 phosphorylation with op-
posing biological outcomes. PKR, PERK, and GCN2 respond
to glucose deﬁciency, but as yet each eIF2 kinase deter-
mines a distinct biological outcome in cells (Figure 3). Al-
though the kinases have evolutionary conserved catalytic
domains, their regulatory domains and their localization
within the cells differs (Wek et al., 2006). Consequently, their
interactions and proximity to diverse survival and apoptotic
factors could partially account for the functional differ-
ences of the kinases in response to glucose deﬁciency.
Furthermore, each eIF2 kinase may undergo distinct
posttranslational modiﬁcations that modulate their spec-
iﬁcity toward eIF2 and other possible substrates in re-
Figure 6. XIAP is required to promote cell survival during conditions of glucose deprivation. Hela cells (A and B) were treated with control
scrambled siRNA or siRNA speciﬁc for XIAP for 24 h and maintained in media containing glucose (Con), media lacking glucose (Gluc),
or media containing glucose supplemented with 50 mM of 2-DG for additional 24 h. Primary XIAP/ and XIAP/ MEFs (C and D) as well
as HCT116 XIAP/ and HCT116 XIAP/ cells (E and F) were then kept in media containing glucose (Con), media lacking glucose (Gluc),
or media containing glucose supplemented with 50 mM of 2-DG for 24 h. (A, C, and E) The percentage of cells in subG1 phase, which
represents cell death, was measured by propidium iodide staining and ﬂow cytometry analysis. Histograms show the average cell death 
SEM calculated from three independent experiments. Two-tailed t test: *p  0.05, **p  0.01. (B, D, and F) Whole cell extract (50 g of protein)
were subjected to immunoblot analysis for the indicated proteins.
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demonstrated an important role of tyrosine phosphory-
lated PKR in the inhibition of protein synthesis through
eIF2 phosphorylation-dependent and -independent
mechanisms (Su et al., 2006).
Inhibition of protein synthesis by eIF2 phosphorylation
is considered as a major cause of apoptosis (Holcik and
Sonenberg, 2005). However, from [35S]methionine metabolic
labeling (Figure 4) and polysome proﬁle analyses (Figure 7),
we found that inhibition of protein synthesis caused by
glucose deﬁciency is independent of eIF2 phosphorylation.
This is different from a typical ER stress response in which
translational inhibition by eIF2 phosphorylation is essen-
tial for cytoprotection (Scheuner et al., 2001). During glucose
deﬁciency we observed that proteins involved in UPR such
as ATF4, CHOP, and BiP were up-regulated in manner that
was dependent on eIF2 phosphorylation (Figure 5).
The stimulation of apoptosis involves a delicate balance
between the inducers (e.g., CHOP) and the inhibitors of
apoptosis (e.g., XIAP). The induction of CHOP in the
eIF2S/S cells explains the cleavage of caspase-3 observed at
early time points in the eIF2S/S (Ma and Hendershot, 2004;
Kim et al., 2008). Although the eIF2S/S cells remain apo-
ptotic, there is a decrease in the execution of apoptosis after
prolonged glucose deﬁciency, this may be explained by the
induction of BiP, which confers cells protection during
stressful conditions (Kim et al., 2008). In addition, XIAP
protein levels were higher in the eIF2S/S cells compared
with the eIF2A/A cells, a ﬁnding that can account for the
protection against apoptosis during stress from glucose de-
ﬁciency (Figures 5 and 6). XIAP is an important regulator of
cell survival because it interferes with the activity of
caspase-3 and -9 (Dubrez-Daloz et al., 2008). The eIF2A/A
cells were not capable of maintaining the levels of XIAP
protein under prolonged glucose deﬁciency. Therefore,
caspase-3 activation and hence accelerated death observed
after prolonged stress in the eIF2A/A cells was consistent
with the decrease in XIAP protein levels. Although XIAP
Figure 7. Induction of eIF2 phosphorylation
facilitates XIAP expression in glucose-deﬁcient
cells at a posttranslational level. eIF2S/S (A)
and eIF2A/A MEFs (B) were kept in media
containing glucose (Con) or in glucose-free
media (Gluc) for 30 h. Lysates were sub-
jected to polysome proﬁle analysis as de-
scribed in Materials and Method. Gradients
were fractionated and absorbance at 254 nm
was recorded (top panels). The distribution of
XIAP and Bcl-xL mRNAs in the fractions of the
sucrose gradients was quantiﬁed by qRT-PCR
(bottom panels), where the underlined frac-
tions in the graphs signify the polysomes. The
graphs represent the mean  SEM of two in-
dependent experiments.
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control (Holcik et al., 1999), our study shows that transla-
tional control of XIAP takes place efﬁciently in glucose-
deﬁcient cells in a manner that is independent of eIF2
phosphorylation (Figure 7). This is different from a recently
described regulation of XIAP mRNA translation by phos-
phorylated eIF2 in response to osmotic stress (Bevilacqua et
al., 2010), indicating the functional relationship between
XIAP translation and eIF2 phosphorylation is dependent
on the type of stress. Additionally, eIF2S/S and eIF2A/A
cells contained similar amounts of cellular XIAP mRNA
(data not shown), as such, XIAP down-regulation in
eIF2A/A cells is a posttranslational event through mecha-
nisms that are not immediately known. For example, inter-
action of XIAP with other proteins such as survivin (Dohi et
al., 2004), HS1-associated protein X1 (HAX-1; Kang et al.,
2010), BMP receptor 2 (Liu et al., 2009), or Notch (Liu et al.,
2007) have been shown to lead to XIAP stabilization by
preventing its ubiquitination and proteasomal degradation.
As such, the possibility remains that phosphorylated eIF2
regulates the expression and/or stability of one or more of
XIAP interacting proteins under glucose deﬁciency. Al-
though in theory treatment of eIF2A/A MEFs with protea-
some inhibitors should prevent the down-regulation of
XIAP under glucose deﬁciency, in practice this experiment
has led to inconclusive results due to high susceptibility of
glucose-starved cells to deleterious side effects of protea-
some inhibitors (data not shown). Another possibility is that
phosphorylated eIF2 regulates expression and/or activity
of a kinase other than Akt that controls XIAP stability. For
example, protein kinase A (PKA) has been implicated in
XIAP destabilization via the phosphorylation of survivin
and disruption of the survivin-XIAP complex (Dohi et al.,
2007). However, to date there is no evidence to suggest a role
of PKA in glucose-deﬁcient cells.
Previous work showed that during ER stress PERK elicits
a cytoprotective response through the induction of the tran-
scription and translation of cIAP1 and cIAP2 in a manner
that relies on eIF2 phosphorylation (Hamanaka et al., 2009).
Contrary to ER stress, however, we observed a down-regu-
lation in cIAP1 and cIAP2 levels in glucose-deﬁcient cells
independent of eIF2 phosphorylation (Figure 5). This is
another indication that glucose deﬁciency does not represent
a typical ER stress response but rather a response that can
integrate various proapoptotic and survival pathways all of
which depend on eIF2 phosphorylation.
There has been an established link between eIF2 phos-
phorylation and regulation of glucose metabolism. That is,
eIF2A/A mice develop hypoglycemia that results in their
death 18 h after birth (Scheuner et al., 2001). Further analysis
demonstrated that these mice develop hepatic failure where
eIF2 phosphorylation is required for the expression of en-
zymes necessary for gluconeogenesis: the making of glucose
molecules from simpler carbon sugars (Scheuner et al., 2001).
Interestingly, PERK/ mice gradually develop diabetes
2–4 wk after birth because of the progressive loss of -cells
(Harding et al., 2001). Further work established that eIF2
phosphorylation is necessary to prevent oxidative damage
and ER stress by regulating the expression of genes that
maintain -cell function and limit oxidative stress (Back et
al., 2009). These ﬁndings together with our data provide
further evidence that eIF2 phosphorylation plays an essen-
tial role in the regulation of glucose homeostasis.
In light of our ﬁndings, it is conceivable to speculate that
eIF2 phosphorylation plays an important role in cancer
development under conditions of low levels of glucose. This
may be an essential process because cancer cells are fre-
quently found in such stressful microenvironments and they
appear to survive better than normal cells under these con-
ditions. The cytoprotective effects of eIF2 phosphorylation
under prolonged glucose deﬁciency might be sufﬁcient to
allow tumor progression and metastasis. Anticancer treat-
ments have recently focused on targeting the glycolytic
pathways of tumor (Pan and Mak, 2007), such that it was
previously shown that 2-DG could be used alone or in
combination with other tumor therapies to increase the ef-
ﬁciency of conventional treatment (Maschek et al., 2004;
Kang and Hwang, 2006). As such, further elucidating the
role of eIF2 phosphorylation in tumor development under
conditions of limited glucose may prove critical for the
development of strategies to bypass the cytoprotective ef-
fects of eIF2 phosphorylation and impair tumor growth.
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